AY has given paid lectures and sat on advisory boards for the following companies with drugs used in affective and related disorders: Flow Neuroscience, Novartis, Roche, Janssen, Takeda, Noema pharma, Compass, Astrazenaca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, Sage, Neurocentrx
The 5 mg dose of tirzepatide has been shown in studies to produce weight loss comparable to maximum-dose semaglutide , with the added benefit of GIP receptor activation
Results vary by individual and the condition being treated
No medical claims are made or implied
BPC-157 stability is comparable to other synthetic peptides of similar molecular weight (approximately 1400 Da)